Skip to content

The analgesic effect of transcutaneous electrical acupoint stimulation on endoscopic spinal surgery: a prospective, randomized, controlled study

The analgesic effect of transcutaneous electrical acupoint stimulation on endoscopic spinal surgery: a prospective, randomized, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080480
Enrollment
Unknown
Registered
2024-01-30
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disk herniation

Interventions

TEAS Group: transcutaneous electrical acupoint stimulation
control group:Placebo

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 18 to 80 years old, ASA level I-II; 2. Diagnose lumbar disc herniation and plan to undergo selective single segment endoscopic surgery for treatment; 3. Use TEAS for intraoperative and postoperative analgesia.

Exclusion criteria

Exclusion criteria: 1. Plan to undergo dual segment endoscopic surgery or open surgery for the spine; 2. There are contraindications for TEAS treatment (such as skin diseases at the treatment site, presence of pacemakers in the body, gel allergy, pregnant women, malignant tumors, sensory loss, etc.); 3. Has received or is currently receiving TEAS treatment before surgery; 4. History of hemorrhagic diseases and abnormal coagulation function (platelet count, prothrombin time, activated partial thrombin time below the lower limit of normal); 5. Preoperative symptoms include schizophrenia, myasthenia gravis, or inability to communicate due to coma, severe dementia, or language disorders; 6. Patients with preoperative LVEF<30%, or with pathological sinus syndrome, severe sinus bradycardia (heart rate<50 beats/min), atrioventricular block of degree II or above, and no implanted pacemaker; 7 patients with severe liver dysfunction (Child Pugh C grade, Attachment 3), severe renal dysfunction (receiving dialysis before surgery), and ASA grade III or above.

Design outcomes

Primary

MeasureTime frame
Lumbar NRS pain score;Lumbar NRS pain score;Lumbar NRS pain score;Lower limb NRS pain score;Lower limb NRS pain score;

Secondary

MeasureTime frame
Lower limb NRS pain score;Intraoperative NRS pain score;sleep quality;Frequency and dosage of remedial analgesia;ODI index;SF-12 score;Lower limb NRS pain score;Intraoperative NRS pain score;Intraoperative NRS pain score;sleep quality;ODI index;SF-12 score;

Countries

China

Contacts

Public ContactShuiqing Li

Peking University Third Hospital

bjfdfx@126.com+86 135 8178 5098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026